S-Nitrosylation: Mechanistic Links between Nitric Oxide Signaling and Atherosclerosis
- PMID: 40772994
- DOI: 10.1007/s11883-025-01321-y
S-Nitrosylation: Mechanistic Links between Nitric Oxide Signaling and Atherosclerosis
Abstract
Purpose of review: This review explores current knowledge on the beneficial and detrimental roles of nitric oxide (NO) in vascular biology, with a particular focus on the emerging role of protein S-nitrosylation in the pathophysiology of atherosclerosis.
Recent findings: Major risk factors for atherosclerosis include hypercholesterolemia, low-density lipoprotein (LDL) oxidation, hyperglycemia, hyperhomocysteinemia, chronic inflammation, and obesity. Recent studies have shown that protein S-nitrosylation interacts with these risk factors, influencing atherogenesis either by promoting or inhibiting disease progression. Atherosclerosis is a chronic inflammatory disorder marked by the accumulation of plaques within arterial walls, arising from intricate interactions among endothelial cells, monocytes/macrophages, and vascular smooth muscle cells. Understanding the role of S-nitrosylation in regulating key cellular events-such as endothelial dysfunction, foam cell formation, and vascular smooth muscle cell proliferation-offers new insights into the molecular mechanisms underlying atherosclerosis. These insights may ultimately lead to the identification of novel therapeutic targets for cardiovascular disease.
Keywords: Atherosclerosis; Cardiovascular Disease; Nitric Oxide; S-nitrosylation.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Human and Animal Rights and Informed Consent: No animal or human subjects by the authors were used in this study.
Similar articles
-
Dysfunction of Microcirculation in Atherosclerosis: Implications of Nitric Oxide, Oxidative Stress, and Inflammation.Int J Mol Sci. 2025 Jul 4;26(13):6467. doi: 10.3390/ijms26136467. Int J Mol Sci. 2025. PMID: 40650241 Free PMC article. Review.
-
Purinergic receptors in atherosclerosis: implications for pathophysiology and therapeutic strategies.J Physiol Biochem. 2025 Jul 16. doi: 10.1007/s13105-025-01108-4. Online ahead of print. J Physiol Biochem. 2025. PMID: 40668534 Review.
-
S-nitrosylation of cardiac myocyte proteins may underlie sex differences in cardiac disease.Front Physiol. 2025 May 6;16:1565917. doi: 10.3389/fphys.2025.1565917. eCollection 2025. Front Physiol. 2025. PMID: 40395646 Free PMC article. Review.
-
Hydrogen Sulfide and Oxygen Homeostasis in Atherosclerosis: A Systematic Review from Molecular Biology to Therapeutic Perspectives.Int J Mol Sci. 2023 May 6;24(9):8376. doi: 10.3390/ijms24098376. Int J Mol Sci. 2023. PMID: 37176083 Free PMC article.
-
Dysregulation of Nitrosylation Dynamics Promotes Nitrosative Stress and Contributes to Cardiometabolic Heart Failure with Preserved Ejection Fraction.bioRxiv [Preprint]. 2024 Dec 23:2024.12.20.629549. doi: 10.1101/2024.12.20.629549. bioRxiv. 2024. PMID: 39763741 Free PMC article. Preprint.
References
-
- Forstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120(4):713–35. - PubMed
-
- Chen JY, et al. Nitric oxide bioavailability dysfunction involves in atherosclerosis. Biomed Pharmacother. 2018;97:423–8. - PubMed
-
- Kuhlencordt PJ, et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001;104(4):448–54. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials